Add to a list

Inactive Instrument

INSTITUT Stock Moscow Micex - RTS

ISKJ

RU000A0JNAB6

Healthcare Facilities & Services

OTC Markets Traded

End-of-day quote Moscow Micex - RTS Other stock markets
- ^USD	-

28/04	Artgen Biotech PJSC Reports Earnings Results for the Full Year Ended December 31, 2025	CI
30/08/25	Artgen Biotech PJSC Reports Earnings Results for the Half Year Ended June 30, 2025	CI

Artgen Biotekh PAO is a Russia-based company engaged in the research and development and invesment in biotechnology. The Company develops and implements drugs, products or methods of treatment, diagnostic and prevention of diseases. The Company invests in assets engaged in development and commercialization of new drugs, medical devices, genetic diagnostics and research and other high-tech products and services related to biomedicine and healthcare. Artgen Biotekh PAO develops a platform for startups and companies to share knowledge related to science, research, production, marketing, business, regulations, patent and other fields. Some of the Company's products are Neovasculgen, a gene therapy drug, vaccines Tetraflubet and Betuvax and others.

Employees

Sector

Healthcare Facilities & Services

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	4.4B 53.56M 46.33M 43.27M 39.69M 74.65M 5.1B 75.84M 508M 199M 2.56B 201M 197M 8.45B	P/E 2024	25.7x	P/E 2025	46.2x
Enterprise Value	4.64B 56.42M 48.8M 45.57M 41.81M 78.63M 5.37B 79.88M 535M 210M 2.69B 212M 207M 8.9B	EV / Sales 2024	3.02x	EV / Sales 2025	2.7x
Free-Float	17.07%	Yield 2024 *	-	Yield 2025	-

28/04	Artgen Biotech PJSC Reports Earnings Results for the Full Year Ended December 31, 2025	CI
30/08/25	Artgen Biotech PJSC Reports Earnings Results for the Half Year Ended June 30, 2025	CI
02/07/25	GENETICO PJSC announced that it has received RUB 238 million in funding from Artgen Biotech PJSC	CI
29/04/25	Artgen Biotech PJSC Reports Earnings Results for the Full Year Ended December 31, 2024	CI
15/10/24	GENETICO PJSC announced that it expects to receive RUB 240 million in funding from Artgen Biotech PJSC	CI
06/09/24	Artgen Biotech PJSC Reports Earnings Results for the Half Year Ended June 30, 2024	CI
27/04/24	Artgen Biotech PJSC Reports Earnings Results for the Full Year Ended December 31, 2023	CI
30/08/23	Artgen Biotech PJSC Reports Earnings Results for the Half Year Ended June 30, 2023	CI
02/05/23	Public Joint-Stock Company "Human Stem Cells Institute" Reports Earnings Results for the Full Year Ended December 31, 2022	CI
25/04/23	GENETICO PJSC has completed an IPO in the amount of RUB 178.8 million.	CI
21/10/22	GENETICO PJSC has filed an IPO.	CI
31/08/22	Public Joint-Stock Company "Human Stem Cells Institute" Reports Earnings Results for the Half Year Ended June 30, 2022	CI
19/08/22	Public Joint-Stock Company "Human Stem Cells Institute" announced that it has received RUB 611.63608 million in funding from PJSC International Medical Center Processings and Kriokhraneniya of Biomaterialy	CI

Manager	Title	Age	Since
Masyuk Sergey Vladimirovich CEO	Chief Executive Officer	-	-
Galina Bulanova DFI	Director of Finance/CFO	-	-
Dmitry Krasotkin CIO	Chief Investment Officer	-	-

Director	Title	Age	Since
Sergey Kiselev BRD	Director/Board Member	68	23/08/2010
Roman Deev BRD	Director/Board Member	47	09/01/2014
Dmitry Aleksandrov BRD	Director/Board Member	45	01/01/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CVS HEALTH CORPORATION	-0.54%	-8.36%	+50.52%	+29.48%	122B
HCA HEALTHCARE, INC.	+1.09%	+2.68%	+10.72%	+51.65%	89.49B
FRESENIUS SE & CO. KGAA	+0.81%	+5.71%	+11.31%	+66.88%	30.64B
QUEST DIAGNOSTICS INCORPORATED	-0.06%	+2.29%	+36.77%	+74.47%	26.31B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-2.13%	-0.26%	-11.21%	-16.82%	21.85B
TENET HEALTHCARE CORPORATION	+2.14%	+2.88%	+60.40%	+246.27%	21.11B
REDE D'OR SÃO LUIZ S.A.	-0.41%	-2.08%	-5.52%	-2.05%	14.65B
FRESENIUS MEDICAL CARE AG	+0.41%	-5.40%	+2.76%	-10.57%	12.88B
DAVITA INC.	+1.72%	-23.46%	+43.92%	+63.09%	11.72B
Average	+0.34%	-2.89%	+22.19%	+55.82%	39.01B
Weighted average by Cap.	+0.21%	-2.47%	+28.36%	+50.26%

INSTITUT Stock Moscow Micex - RTS

Stocks

ISKJ

RU000A0JNAB6

Healthcare Facilities & Services

Valuation: INSTITUT

Latest news : INSTITUT

Managers and Directors: INSTITUT

Other Healthcare Facilities & Services

Financials

Company Profile

	2024	2025
Net sales	1.52B 18.52M 16.02M 14.96M 13.72M 25.81M 1.76B 26.22M 175M 68.88M 883M 69.53M 68.01M 2.92B	1.72B 20.89M 18.07M 16.87M 15.48M 29.11M 1.99B 29.57M 198M 77.69M 996M 78.43M 76.71M 3.29B
Net income	215M 2.62M 2.26M 2.11M 1.94M 3.65M 249M 3.7M 24.79M 9.73M 125M 9.82M 9.61M 412M	96.95M 1.18M 1.02M 953K 874K 1.64M 112M 1.67M 11.18M 4.39M 56.28M 4.43M 4.33M 186M
Net Debt	199M 2.42M 2.1M 1.96M 1.8M 3.38M 231M 3.43M 22.97M 9.02M 116M 9.1M 8.9M 382M	234M 2.85M 2.47M 2.31M 2.11M 3.98M 272M 4.04M 27.05M 10.62M 136M 10.72M 10.48M 450M